Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
autoimmune disease
Biotech
Zenas bags $200M series C to reach a handful of key mAB readouts
Zenas' $200 million series C is the company's second consecutive nine-digit financing.
Max Bayer
May 7, 2024 7:00am
BMS pays $65M to expand Repertoire of autoimmune assets
Apr 29, 2024 6:15am
Sanofi crosses Sjögren's off $5B drug's hit list after phase 2
Apr 25, 2024 2:35am
Sanofi nails phase 3 LUNA landing, sparking race to regulators
Apr 23, 2024 2:23am
Roivant's inflammatory med is back on track with ph. 2 NIU data
Apr 2, 2024 10:37am
Ginkgo loads up Modulus CAR assets, latest in a string of deals
Apr 2, 2024 7:01am